Fri, Aug 22, 2014, 7:15 AM EDT - U.S. Markets open in 2 hrs 15 mins

Recent

% | $
Quotes you view appear here for quick access.

Celsion Corp. Message Board

  • smilee142003 smilee142003 Jan 1, 2013 11:34 PM Flag

    interesting conversation

    on twitter. Someone else takes on biotech sage...

    Wilson Zhang ‏@WilsonZhang2011
    @BiotechSage Another mistake in SA article: T-dox in plasma doesn't mean it's NOT available to be deposited at liver when it circulates.
    Expand
    1h BiotechSage ‏@BiotechSage
    @BiotechSage @WilsonZhang2011 The data is clear from the PK curve. The bulls prefer to ignore it and focus on some select preclinical work
    Expand
    1h Wilson Zhang ‏@WilsonZhang2011
    @BiotechSage Dr. Poon's comment is specific to P1, not any preclinical work. The prest. is made 3 months ago. Are you calling him a fraud?
    Expand
    1h BiotechSage ‏@BiotechSage
    @WilsonZhang2011 Maybe. Don't know the guy. But it seems more likely that you are wrongly interpreting the PK curve
    Expand
    54m Wilson Zhang ‏@WilsonZhang2011
    @BiotechSage Possible. Unless Dr. Poon(famous in HCC field) is a fraud, it's you who have misread the PK curve. What's your play in $CLSN?

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • alark13@ymail.com alark13 Jan 2, 2013 8:19 AM Flag

      Thanks smilee... here is my take... Sage likely does not have a position in CLSN at all or if he does it is a small one... he is a paid assassin with a background that prepares him to write and argue intelligently on the matter... however, he does not wish to put his professional reputation at stake because he does not identify himself... that way he can hide in the shadows and publish for pay, doing the bidding of his masters... anyone with proper training and background could find some points to raise in the development of any treatment indication... jmo...

      So from the twitter exchange you chronicle... this is what one has to believe to accept Sage's end of it... there is a fatal flaw in the pre-clinical PK... a fatal flaw... that only he can see... that Dr. Poon missed... that the other researchers at CLSN missed... that the researchers at Duke University missed... that the FDA missed in approving the jump from P1 to P3 by-passing P2... that the scientists at Phillips missed... that the scientists at Hisun missed... but Sage found it... no wonder he is called "Sage"... he sounds like a super hero to me...

    • kinda says it all; sure he doesn't know "the guy" but he doesn't even recognize that he's an expert in this field who has risked his reputation on these trials

      biotechsage just wants to ignore dr poon and the insiders; seems like a real bad move on his part

      @WilsonZhang2011 Maybe. Don't know the guy. But it seems more likely that you are wrongly interpreting the PK curve

      Sentiment: Strong Buy

    • That wasn't all of it ("90%!"):

      BiotechSage ‏@BiotechSage
      @WilsonZhang2011 @BiotechSage Im short stock and long puts. HEAT will fail 90% prob
      Details
      42m Wilson Zhang ‏@WilsonZhang2011
      @BiotechSage are you long puts or short stock?
      Details

      Sentiment: Strong Buy

    • So, what does this chatter imply or mean?

 
CLSN
3.14+0.02(+0.64%)Aug 21 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.